Prima BioMed to Maintain NASDAQ Listing
(firmenpresse) - SYDNEY, AUSTRALIA -- (Marketwired) -- 01/18/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) the "Company" has received notification from the Listing Qualifications Department of the NASDAQ Stock Market indicating that the Company''s American Depositary Shares have maintained a closing bid price of US$1.00 per share or greater for 10 consecutive business days from 28 December 2016 to 11 January 2017. Accordingly, the Company has regained compliance with NASDAQ Listing Rule 5450(a)(1) (the "Minimum Bid Price Rule") and the Company''s American Depositary Shares will remain listed on the NASDAQ Global Market.
Prima BioMed is listed on the Australian Securities Exchange and on the NASDAQ in the US. For further information please visit .
Mr. Matthew Beck
The Trout Group LLC
+1 (646) 378-2933
Mr. Matthew Gregorowski
Citadel-MAGNUS
+61 2 8234 0100
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 18.01.2017 - 01:02 Uhr
Sprache: Deutsch
News-ID 1480982
Anzahl Zeichen: 4922
contact information:
Contact person:
Town:
SYDNEY, AUSTRALIA
Phone:
Kategorie:
Biotech
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 227 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Prima BioMed to Maintain NASDAQ Listing
"
steht unter der journalistisch-redaktionellen Verantwortung von
PRIMA BIOMED LTD (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
